KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Medpace Holdings (MEDP) Assets: 2015-2025

Historic Assets for Medpace Holdings (MEDP) over the last 9 years, with Sep 2025 value amounting to $1.8 billion.

  • Medpace Holdings' Assets fell 15.88% to $1.8 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $1.8 billion, marking a year-over-year decrease of 15.88%. This contributed to the annual value of $2.1 billion for FY2024, which is 26.80% up from last year.
  • Latest data reveals that Medpace Holdings reported Assets of $1.8 billion as of Q3 2025, which was up 11.54% from $1.6 billion recorded in Q2 2025.
  • Medpace Holdings' Assets' 5-year high stood at $2.1 billion during Q4 2024, with a 5-year trough of $1.3 billion in Q2 2022.
  • Its 3-year average for Assets is $1.7 billion, with a median of $1.8 billion in 2025.
  • In the last 5 years, Medpace Holdings' Assets decreased by 18.52% in 2022 and then soared by 40.18% in 2024.
  • Over the past 5 years, Medpace Holdings' Assets (Quarterly) stood at $1.7 billion in 2021, then fell by 18.52% to $1.4 billion in 2022, then grew by 22.50% to $1.7 billion in 2023, then grew by 26.80% to $2.1 billion in 2024, then declined by 15.88% to $1.8 billion in 2025.
  • Its Assets was $1.8 billion in Q3 2025, compared to $1.6 billion in Q2 2025 and $1.9 billion in Q1 2025.